Blood glucose test strips (blood glucose test strips)
Status:
Concluded with an LOI
Manufacturer:
Tykess Pharmaceuticals Inc.
Indication:
Diabetes Mellitus, Type 1 & 2
Last updated August 12, 2021
Status:
Concluded with an LOI
Manufacturer:
Merck Canada Inc.
Indication:
Unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer (CRC), for first-line treatment of adult patients
Last updated August 11, 2021
Status:
Concluded with an LOI
Manufacturer:
GlaxoSmithKline Inc.
Indication:
Ovarian Cancer: Maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to first-line platinum-based chemotherapy
Last updated August 11, 2021
Status:
Concluded with an LOI
Manufacturer:
GlaxoSmithKline Inc.
Indication:
Ovarian Cancer, monotherapy for the maintenance treatment of female adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy
Last updated August 11, 2021
Status:
Concluded with an LOI
Manufacturer:
Astellas Pharma Inc.
Indication:
Metastatic Castration-Sensitive Prostate Cancer
Last updated July 30, 2021
Status:
Negotiations were not pursued
Manufacturer:
Celgene Inc.
Indication:
Multiple Sclerosis, Relapsing-Remitting
Last updated July 29, 2021
Status:
Concluded without agreement
Manufacturer:
Janssen Inc.
Indication:
Ulcerative Colitis
Last updated July 28, 2021
Suboxone (film) (buprenorphine and naloxone)
Status:
Concluded with an LOI
Manufacturer:
Indivior UK Limited
Indication:
Opioid Dependence
Last updated July 15, 2021
Status:
Concluded with an LOI
Manufacturer:
Hoffmann-La Roche Ltd.
Indication:
ROS1-positive Non-Small Cell Lung Cancer
Last updated July 6, 2021
Status:
Concluded with an LOI
Manufacturer:
Elvium Life Sciences
Indication:
Attention-deficit/hyperactivity disorder (ADHD)
Last updated June 29, 2021